What's the difference between fungoid and funguslike?
Fungoid
Definition:
(a.) Like a fungus; fungous; spongy.
Example Sentences:
(1) The platelet cytotoxic action on tumor cells was studied in patients with mycosis fungoides and Kaposi's sarcoma.
(2) Of these, 64 were in Group 1 (mycosis fungoides, MF), 23 in Group II (Sézary syndrome, SS), and 20 in Group III (non-Hodgkin's lymphoma, NHL).
(3) Mycosis fungoides was found in the lymph nodes of 3 of these patients, in the spleen in 4 and in the liver in 2 cases.
(4) Response rates were as follows: 14.3% (renal cell cancer), 11.8% (multiple myeloma) 40.0% (chronic lymphocytic leukemia), 16.7% (non-Hodgkin lymphoma), and 67% (mycosis fungoides).
(5) This term encompasses the spectrum of the traditional mycosis fungoides and Sézary syndrome.
(6) This striking therapeutic effect parallels reports of regression of mycosis fungoides and chronic generalized lymphadenopathy after acyclovir application.
(7) On the basis of these results DNA-cytophotometry may be considered an additional and objective aid in the diagnosis of lymph node involvement in mycosis fungoides.
(8) Previously acquired cellular immunity was found equal in the two groups, however, induction of cellular hypersensitivity to brucella antigen was found depressed in mycosis fungoides patients compared with the controls.
(9) No positive staining was seen in 238 cases of T-CLL, mycosis fungoides, Sèzary-syndrome, B-CLL, hairy cell leukemia, multiple myeloma and T- and B-lymphoma nor in 32 cases of B-ALL, Burkitt-lymphoma, Null-ALL and immature T-lymphoma.
(10) Mycosis fungoides (MF) and Sézary syndrome (SS) are malignant non-Hodgkin's lymphomas, characterized by the proliferation of helper type T lymphocytes with a predilection for the skin.
(11) Three hundred fifty-six patients with mycosis fungoides or Sézary syndrome.
(12) Four patients with mycosis fungoides in stages I to IV had a highly elevated serum IgE, while serum IgE in remaining patients was slightly elevated, normal, or subnormal.
(13) The results of interferon alpha in cutaneous T-cell lymphoma and mycosis fungoides are controversial.
(14) As a group, mycosis fungoides (MF) patients could be distinguished from those with benign disorders of skin using ultrastructural morphometry (mean form factor and perimeter values), but with some overlap between groups.
(15) This report documents the development of multiple cutaneous tumors, including squamous cell carcinoma, basal cell carcinoma, actinic keratoses, keratoacanthomas, and one case of lentigo maligna, in seven patients who received topical therapies for mycosis fungoides.
(16) Five patients with a cutaneous T-cell lymphoma (four with mycosis fungoides and one with a primary cutaneous T-immunoblastic lymphoma) who developed neurological sequelae are reported.
(17) This new therapy has proved very good in psoriasis, acne, bacterial disseminated eczema, parapsoriasis and mycosis fungoides.
(18) These findings support further the view that large plaque parapsoriasis represents an important precursor of mycosis fungoides.
(19) The development of a rationale for the treatment of patients with all stages of mycosis fungoides based upon these clincal observations is discussed.
(20) Increased detection of both p-62 and p-21 in atypic lymphoid cells was shown in advanced stages of Mycosis Fungoides (third stage plaques and tumors) as compared to early stages (premycotic erythema, second stage plaques).